Acadia Pharmaceuticals (ACAD) Operating Expenses (2010 - 2026)
Acadia Pharmaceuticals (ACAD) posted quarterly Operating Expenses of $272.7 million for Q1 2026, up 21.18% year-over-year from $225.0 million in Q1 2025, and up 2.28% quarter-over-quarter from $266.6 million in Q4 2025.
Acadia Pharmaceuticals (ACAD) Operating Expenses (2010 - 2026) Analysis & Trends
Acadia Pharmaceuticals' Operating Expenses history runs 17 years deep, the most recent figure standing at $272.7 million for Q1 2026.
- In Q1 2026, Operating Expenses rose 21.18% year-over-year to $272.7 million; the TTM figure through Mar 2026 stood at $1.0 billion (up 33.22% YoY), while the FY2025 annual figure was $966.7 million, up 32.97% from the prior year.
- Operating Expenses for Q1 2026 stood at $272.7 million, up from $266.6 million in the prior quarter.
- The five-year high for Operating Expenses was $272.7 million in Q1 2026, with the low at $106.1 million in Q4 2024.
- The 5-year median for Operating Expenses is $211.5 million (2024), against an average of $206.3 million.
- The sharpest annual moves came in 2024 and 2025: Operating Expenses plunged 45.89% in 2024, then soared 151.27% in 2025.
- Acadia Pharmaceuticals' Operating Expenses stood at $182.6 million in 2022, then climbed by 7.42% to $196.1 million in 2023, then slumped by 45.89% to $106.1 million in 2024, then jumped by 151.27% to $266.6 million in 2025, then gained by 2.28% to $272.7 million in 2026.
- Business Quant data shows ACAD's Operating Expenses at $272.7 million in Q1 2026, $266.6 million in Q4 2025, and $242.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Acadia Pharmaceuticals | 4.86 Bn | 3.90 Bn | 279.64 Mn | 270.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 270.12 Mn |
| Mar 31, 2026 | 272.68 Mn |
| Dec 31, 2025 | 266.60 Mn |
| Sep 30, 2025 | 242.88 Mn |
| Jun 30, 2025 | 232.19 Mn |
| Mar 31, 2025 | 225.03 Mn |
| Dec 31, 2024 | 106.10 Mn |
| Sep 30, 2024 | 218.76 Mn |
| Jun 30, 2024 | 211.53 Mn |
| Mar 31, 2024 | 190.62 Mn |
| Dec 31, 2023 | 196.10 Mn |
| Sep 30, 2023 | 269.48 Mn |
| Jun 30, 2023 | 162.20 Mn |
| Mar 31, 2023 | 172.05 Mn |
| Dec 31, 2022 | 182.55 Mn |
| Sep 30, 2022 | 161.58 Mn |
| Jun 30, 2022 | 168.21 Mn |
| Mar 31, 2022 | 228.48 Mn |
| Dec 31, 2021 | 175.42 Mn |
| Sep 30, 2021 | 146.91 Mn |